W Health Ventures
W Health Ventures is a healthcare-focused venture capital firm founded in 2021 that invests USD 1-5M in early-stage (Seed to Series A) digital health startups across India and the US-India corridor, operating alongside venture studio 2070Health.
- Company typePrivate
- Founded2021
- HeadquartersBoston, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What W Health Ventures does
W Health Ventures is a healthcare-focused venture capital firm founded in 2021 and domiciled in Boston, USA, with a registered office in Delhi and operating presence in Mumbai and Bengaluru. The firm invests in early-stage digital health and healthcare delivery startups at Seed through Series A stages, deploying USD 1-5M per company in exchange for equity. Fund I has deployed over $50M across 12+ portfolio companies spanning single-specialty care delivery (Nivaan Care, Everhope, BabyMD/Hoola Health), AI-enabled mental health (Wysa, Everbright Health), chronic disease management (BeatO, Ryse Health, Mylo), and specialized healthcare services (Reveal Healthtech, Jasper, Kins, Violet), collectively touching 25M+ lives.
The firm operates alongside 2070Health, India's first healthcare-focused venture studio that builds healthcare companies from scratch, providing both capital investment and hands-on operational support including critical hiring, strategic expansion, GTM experimentation, and future fundraising support. This venture studio model differentiates W Health from pure financial investors by enabling company creation from ideation through growth. The firm has formed strategic clinical partnerships, most notably with Narayana Health for the $10M day-zero investment in Everhope Oncology, and regularly co-invests with syndicates including Sorin Investments, Leo Capital, Peak XV's Surge, Endiya Partners, and Rebright Partners.
Fund II, with a target corpus of INR 630 crore (~USD 70-75M), achieved its first close at INR 550 crore (~USD 60.7M) in February 2026 and is registered as a Category II AIF with SEBI. Fund II explicitly targets AI-enabled healthcare startups with a focus on chronic care management, oncology, mental health, and preventive care, planning to build 8-10 companies over four years with INR 30-50 crore per company. Capital allocation is two-thirds India and one-third US, formalizing a US-India corridor strategy. Revenue for the firm is generated through traditional venture capital mechanics: management fees on committed capital plus carried interest upon successful portfolio exits, with no public revenue disclosure.
W Health Ventures firmographics
Firmographics- Name
- W Health Ventures
- Legal name
- W Health Ventures Corporation
- Website
- https://whealthventures.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- W Health Ventures is a healthcare-focused venture capital firm founded in 2021 that invests USD 1-5M in early-stage (Seed to Series A) digital health startups across India and the US-India corridor, operating alongside venture studio 2070Health.
- Ownership category
- akta.pro rank
W Health Ventures industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- Open-End Investment Funds (525910)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
- akta.pro secondary industry
- Healthcare Access & Life Sciences Impact Funds (FSANAJAI)
Keywords
Where W Health Ventures is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
W Health Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
Revenue model
- Fund Management / Carry: W Health Ventures generates returns through equity ownership in portfolio companies. The firm earns carry (performance fees) when portfolio companies achieve successful exits through acquisitions or IPOs. First fund deployed $50M+ across 12+ companies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
W Health Ventures product offering
Product offeringCore offering
W Health Ventures is a healthcare-focused venture capital firm that invests USD 1-5M equity tickets into early-stage (Seed to Series A+) digital health and healthcare delivery startups in India and the US-India corridor. Operating alongside venture studio 2070Health, the firm both deploys capital and co-builds companies from scratch, providing hands-on operational support in critical hiring, strategic expansion, follow-on fundraising, and go-to-market experimentation.
Product overview
W Health Ventures is a healthcare-focused venture capital and company-building firm operating in India and the US-India corridor. The firm operates two funds (Fund I and Fund II with target corpus of INR 630 crore) and partners with 2070Health, India's first healthcare-focused venture studio, to build healthcare companies from scratch. The portfolio includes 16+ companies across India and US spanning single-specialty care delivery (Nivaan Care, Everhope, BabyMD/Hoola Health), AI-enabled mental health (Wysa, Everbright Health), chronic disease management (BeatO, Ryse Health, Mylo), and specialized healthcare services (Reveal Healthtech, Jasper, Kins, Violet, Good Health Company, Elevate Now). The firm has deployed over $50M across 12+ companies touching 25M+ lives.
Differentiator
Problem solved
Functional benefit
Brands
- W Health Ventures Fund I: First fund of W Health Ventures that invested in 12+ healthcare startups
- W Health Ventures Fund II
Products and services
- W Health Ventures Fund I First healthcare-focused investment fund of W Health Ventures that invests USD 1M-5M equity tickets into early-stage healthcare startups at Seed to Series A stages in India and the US-India corridor, for Limited Partner investors seeking healthcare venture capital exposure.
- W Health Ventures Fund II Second healthcare-focused investment fund of W Health Ventures targeting a corpus of INR 630 crore, with focus on AI-enabled healthcare startups, chronic care management, oncology, mental health, and preventive care, deployed as USD 1-5M equity tickets into 8-10 portfolio companies over four years, for Limited Partner investors.
- 2070Health Venture Studio India's first healthcare-focused venture studio that builds healthcare companies from scratch alongside W Health Ventures, for healthcare entrepreneurs at the ideation stage who need co-founding support, deep industry expertise, and broad skill sets to launch their companies.
Quantifiable outcome
- Transformed healthcare for 25M+ lives through portfolio companies
- +2 more outcomes
Companies that use W Health Ventures
Customer profileNamed customers16 records
Segments4 records
Ideal customer profiles2 records
W Health Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
W Health Ventures partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and flagship.
- Narayana HealthcoreNarayana Health partnered with W Health Ventures to co-launch Everhope Oncology, a $10 million day-zero investment to build an integrated oncology care platform. Narayana Health provides clinical expertise and infrastructure for the cancer care startup, while W Health Ventures provides capital and operational support through their venture studio model.
- 2070 Healthflagship2070 Health is India's first healthcare-focused venture studio that builds companies from scratch. It operates alongside W Health Ventures with overlapping leadership and support teams. W Health Ventures provides funding for companies with live operations and initial traction, while 2070 Health supports entrepreneurs at the ideation stage. The two entities share deep industry expertise and broad skill sets.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
W Health Ventures competitors and assessment
Company assessmentDirect peers
- Khosla Ventures: Early-stage venture capital firm with significant healthcare and digital health exposure, often backing bold, first-of-their-kind companies. Comparable to W Health Ventures due to early-stage investing, focus on transformative healthcare, and willingness to take concentrated bets on outlier outcomes.
- Andreessen Horowitz (a16z Bio/Health): Operates a dedicated Bio + Health fund focused on digital health, biotech, and care delivery startups. Comparable to W Health Ventures due to large-scale healthcare investing and focus on AI-enabled and digital-first health companies at similar stages.
- Optum Ventures: The dedicated venture arm of Optum/UnitedHealth Group, focused on healthcare technology and services investing. Comparable to W Health Ventures due to specialized healthcare-only focus, partnership-driven approach with strategic operators, and similar stage preferences in digital health.
- General Catalyst: A leading US-based venture capital firm with deep healthcare focus, investing across digital health, biotech, and care delivery. Directly comparable to W Health Ventures due to similar healthcare-only thesis, early-to-growth stage investing, and emphasis on company-building partnerships with strategic operators.
- Endiya Partners: India-based early-stage VC firm with significant healthcare and digital health focus. Comparable to W Health Ventures due to India-centric healthcare investing, similar Seed-to-Series A ticket sizes, and a frequent co-investment relationship evidenced in the Nivaan Care Series A.
- Chiratae Ventures: One of India's largest tech-focused VC firms with deep healthcare and consumer health investments. Comparable to W Health Ventures due to Indian market focus, healthcare portfolio, and similar stage preferences in early-stage digital health.
Broad incumbents
- Norwest Venture Partners: Large multi-stage VC with a dedicated healthcare practice covering digital health, medical devices, and services with India exposure. Comparable to W Health Ventures in healthcare thesis and early-to-growth stage preference, though at much larger fund size and broader geographic footprint.
- Bessemer Venture Partners: Large multi-stage VC with a dedicated healthcare practice covering digital health, biotech, and care delivery. Comparable to W Health Ventures in healthcare thesis, though BVP operates at significantly larger fund sizes and global scale with a much broader portfolio across sectors.
- Sequoia Capital / Peak XV: Global VC firm with India operations as Peak XV, with significant healthcare and digital health exposure. Comparable to W Health Ventures in Indian healthcare market focus; has co-invested in W Health portfolio companies via the Surge program, validating syndicate dynamics.
Emerging players
- High Alpha: US-based venture studio that builds B2B SaaS companies from scratch with operational support and a focused fund model. Comparable to W Health Ventures via the venture studio + fund hybrid model (similar to 2070Health), though focused on SaaS verticals rather than healthcare.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
W Health Ventures social profiles
Digital presenceW Health Ventures compliance and trust
Trust signalCompliance1 record
W Health Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
W Health Ventures leadership team
Management profileNumber of profiles
Profiles13 records
W Health Ventures subsidiaries and ownership
Company hierarchySubsidiaries1 record
W Health Ventures funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
W Health Ventures M&A and investment
M&A and investmentM&A
Investments20 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about W Health Ventures
What does W Health Ventures do?
W Health Ventures is a healthcare-focused venture capital firm that invests USD 1-5M equity tickets into early-stage (Seed to Series A+) digital health and healthcare delivery startups in India and the US-India corridor. Operating alongside venture studio 2070Health, the firm both deploys capital and co-builds companies from scratch, providing hands-on operational support in critical hiring, strategic expansion, follow-on fundraising, and go-to-market experimentation.
Is W Health Ventures a public or private company?
W Health Ventures is a private company. It is classified as unknown and is currently operating.
When was W Health Ventures founded?
W Health Ventures was founded in 2021. It employs 1 to 10 people.
Where is W Health Ventures based?
W Health Ventures is headquartered in Boston, United States, in the North America region.
How does W Health Ventures make money?
One revenue line is on record: fund Management / Carry.
Who are W Health Ventures's main competitors?
Direct peers on record are Khosla Ventures, Andreessen Horowitz (a16z Bio/Health), Optum Ventures, General Catalyst, Endiya Partners and Chiratae Ventures. Broad incumbents are Norwest Venture Partners, Bessemer Venture Partners and Sequoia Capital / Peak XV. High Alpha is listed as an emerging player.
Does W Health Ventures have an API?
No public API is recorded for W Health Ventures.
What industry is W Health Ventures in?
W Health Ventures's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAJAI, Healthcare Access & Life Sciences Impact Funds. Its NAICS code is 525910 and its SIC code is 6282.